Type 2 diabetes is a major global health concern, and is predicted to affect between 10% to 25% of the world's population in the next 20 years. This epidemic is mostly attributed to ageing populations and unhealthy lifestyles. Thusly, understanding how the mind interacts with the body is essential in unlocking the psychological, biological, and sociocultural processes that increase the risk of type 2 diabetes and make it such a difficult condition to treat. Depression is a common co-morbid condition and when both conditions are present, this poses a significant challenge to patients, clinicians, and health care systems globally. Depression and Type 2 Diabetes is a unique resource offering a fresh scientific approach to this frequent co-morbidity. Using the latest research and guidelines, this resource provides readers with a comprehensive overview of the subject at the different stages of human lifespan, from the uterine environment where the metabolic thermostat is first set, to growing old with diabetes. Written and edited by international experts in diabetes and depression, Depression and Type 2 Diabetes reviews, critiques, and advances the latest research on the prevalent and complex relationship between depression and type 2 diabetes. About the Editors: Khalida Ismail is Professor of Psychiatry and Medicine in the Department of Psychological Medicine at the Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. Andreas Barthel is Associate Professor of Medicine, Department of Medicine III at University Hospital Carl Gustav Carus, Dresden and Faculty of Medicine of the TU Dresden, Dresden, Germany. Stefan R. Bornstein is Professor of Medicine in the Department of Medicine III at University Hospital Carl Gustav Carus, Dresden and Faculty of Medicine of the TU Dresden, Dresden, Germany. Julio Licinio is Deputy Director at College of Medicine, State University of New York, Upstate Medical University, Syracuse, USA. |